Kathryn Ruddy

Dr Ruddy is a breast medical oncologist at Mayo Clinic Rochester who co-leads the Symptom Control/Survivorship Cross-Disciplinary Group and the Population Sciences Program for Mayo Clinic Cancer Center across all Mayo Clinic sites. Cardiotoxicity is one of her primary research interests, and she is co-PI of an R01-funded clinical trial assessing carvedilol as a cardioprotectant during Her2-directed therapy for breast cancer. she is a member of the NCCN Survivorship Guidelines Committee, a vice chair of the Symptom Intervention Committee in the Alliance for Clinical Trials in Oncology, and an Associate Editor at JNCI and at JACC Cardio-Oncology.